GO:0017124 SH3 domain binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0017124 (SH3 domain binding) is a molecular function describing the binding of a protein to an SH3 domain, a compact module of about 50 amino acids found in many intracellular and membrane-associated proteins.
• SH3 domains recognize short proline-rich motifs, typically containing a PxxP core, but binding specificity is tuned by surrounding residues and by the domain itself.
• SH3-domain-mediated interactions are central to signal transduction, cytoskeletal regulation, endocytosis, and peroxisomal protein import.
• The binding pathway often involves a disordered encounter complex before the final bound state, as shown for the yeast Abp1p SH3 domain.
• SH3 domain binding can be modulated by adjacent domains, such as the Grb2 SH2 domain, which dictates binding selectivity without changing the folding pathway.
• Dysregulated SH3 domain interactions are implicated in cancer, developmental disorders, and neurodegenerative diseases, making them attractive targets for CRISPR-based functional studies.
Description
SH3 domain binding (GO:0017124) is a molecular function that describes the selective interaction of a protein or peptide with an SH3 (Src homology 3) domain. SH3 domains are small protein modules of approximately 50 amino acid residues that are present in a wide variety of intracellular and membrane-associated proteins. These domains typically recognize proline-rich sequences, and their binding properties are fundamental to the assembly of dynamic signaling complexes. Understanding SH3 domain binding is therefore essential for dissecting how cells transmit signals, remodel their cytoskeleton, and traffic proteins and membranes. Researchers study SH3 domain binding to uncover the rules of modular protein-protein interactions. Although a consensus PxxP motif was initially proposed, it is now clear that specificity arises from additional contacts and from the structural context of both the SH3 domain and its ligand. For example, the C-terminal SH3 domain of Drosophila Drk binds Sos and Dos with distinct affinities, illustrating how subtle sequence variations can direct partner selection. Similarly, the Grb2 C-terminal SH3 domain shows altered binding selectivity when its contiguous SH2 domain is present, highlighting the importance of multidomain architecture. From a disease perspective, SH3 domain binding is relevant to cancer, where aberrant interactions can drive proliferation and metastasis, and to neurological disorders, where disrupted signaling contributes to pathogenesis. The peroxisomal import receptor PEX13 uses an SH3 domain and a proximal FxxxF motif to mediate protein import, linking SH3 binding to metabolic and developmental disorders. Because of this broad relevance, SH3 domain binding is a frequent target for functional genomics, structural biology, and CRISPR-based perturbation studies.
SH3 domain binding At A Glance
| GO ID | GO:0017124 |
|---|---|
| GO term | SH3 domain binding |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding to an SH3 domain, a ~50-amino-acid module that mediates protein-protein interactions, often via proline-rich motifs. |
| Domain size | Approximately 50 amino acid residues. |
| Typical ligands | Proline-rich sequences, often containing a PxxP core, with specificity determined by flanking residues. |
| Cellular context | Intracellular and membrane-associated proteins, including signaling adaptors, cytoskeletal regulators, and trafficking factors. |
| Related processes | Signal transduction, cytoskeletal dynamics, endocytosis, and peroxisomal import. |
What Is GO:0017124?
According to the Gene Ontology, GO:0017124 (SH3 domain binding) is defined as the binding to an SH3 domain (Src homology 3) of a protein. SH3 domains are small protein modules containing approximately 50 amino acid residues that are found in a great variety of intracellular or membrane-associated proteins. In practice, this term is used to annotate any protein or peptide that physically interacts with an SH3 domain, regardless of whether the interaction is transient or stable, and it is a child of the broader molecular function category of protein domain binding.
Why Is SH3 domain binding Important in Cell Biology?
SH3 domain binding is important because it governs the assembly and regulation of multiprotein signaling complexes that control cell growth, shape, and communication. The interaction between SH3 domains and their targets is a paradigm for modular protein recognition, and its dysregulation is linked to cancer, immune disorders, and developmental defects. Moreover, the binding pathway itself, including the formation of disordered encounter complexes, provides insights into how cells achieve rapid and specific responses to signals. Because SH3 domains are abundant and structurally well-defined, they serve as excellent models for studying binding specificity and for developing inhibitors or engineered binding proteins.
• SH3 domain binding is a core mechanism for signal transduction, enabling adaptor proteins like Grb2 to link activated receptors to downstream pathways.
• It regulates cytoskeletal dynamics through proteins such as dynamin, which contains SH3 binding domains important for endocytosis.
• SH3 domain interactions are critical for peroxisomal protein import, as shown by the PEX13 SH3 domain and its FxxxF motif.
• Altered SH3 domain binding can contribute to cancer by promoting uncontrolled proliferation and survival.
• The binding pathway often involves a disordered encounter complex, which affects kinetics and specificity.
• SH3 domain binding is a target for protein-binding arrays and high-throughput screening to identify new interaction partners.
• Understanding SH3 domain binding helps in the design of inhibitors that can disrupt pathological interactions.
• It is essential for the function of many intracellular pathogens that mimic or hijack host SH3-mediated signaling.
• SH3 domain binding is conserved from yeast to humans, making model organisms valuable for functional studies.
• CRISPR-based editing of SH3 domain-containing genes or their binding motifs can reveal causal roles in disease.
Molecular Mechanism of SH3 domain binding
Recognition of proline-rich motifs
In simple terms: SH3 domains grab onto short, proline-rich sequences in partner proteins.
SH3 domains typically bind to proline-rich sequences that adopt a polyproline II helix, often containing a PxxP core motif. The binding interface involves conserved aromatic residues in the SH3 domain that form pockets for proline residues, and specificity is modulated by residues flanking the core motif. This recognition mechanism allows a single SH3 domain to interact with multiple partners with varying affinities, enabling combinatorial signaling.
Encounter complex and binding pathway
In simple terms: Before locking in, the two proteins bump into each other in a loose, disordered way.
Experimental and computational studies of the yeast Abp1p SH3 domain have shown that binding proceeds through a disordered encounter complex, where the ligand is not yet fully folded onto the domain. This encounter complex is central to the binding pathway and can influence the overall association rate and specificity. Such mechanisms are thought to be general for many SH3 domain interactions, providing a dynamic search process before the final locked conformation.
Modulation by adjacent domains
In simple terms: Neighboring domains can change how an SH3 domain chooses its partners.
The binding selectivity of the C-terminal SH3 domain of Grb2 is dictated by its contiguous SH2 domain, but this modulation does not alter the folding pathway of the SH3 domain itself. This demonstrates that multidomain context can fine-tune SH3 domain binding without changing the intrinsic folding mechanism. Such interdomain regulation is important for understanding how adaptor proteins achieve signaling specificity.
Structural and biophysical characterization
In simple terms: Scientists use X-ray crystallography and other methods to see exactly how SH3 domains bind.
SH3 domain binding has been characterized using X-ray crystallography, NMR, and biophysical assays. For example, nickel binding to the c-Src SH3 domain facilitates crystallization, providing structural insights into the domain. Protein-binding arrays have also been developed to profile SH3 domain interactions in a high-throughput manner. These methods reveal the atomic details of binding and help identify specificity determinants.
Specificity and consensus
In simple terms: There is no single perfect sequence; each SH3 domain has its own preferences.
Although a consensus PxxP motif was initially proposed, it is now clear that SH3 domain binding specificity is determined by a combination of the core motif and additional contacts outside the PxxP region. Studies on Drosophila Drk SH3 domains binding to Sos and Dos show that even closely related ligands can be discriminated. Thus, specificity is encoded in both the SH3 domain and the ligand, and can be modulated by cellular context.
Key Genes Involved in GO:0017124 SH3 domain binding
The following genes encode proteins that either contain SH3 domains or are known to bind SH3 domains, and they are frequently studied in the context of GO:0017124.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SRC | Non-receptor tyrosine kinase containing an SH3 domain; regulates proliferation and adhesion. | Model for SH3 domain structure and inhibitor development. |
| GRB2 | Adaptor protein with SH3 domains; links receptor tyrosine kinases to Ras signaling. | Studying SH3 domain selectivity and multidomain regulation. |
| DNM1 | Dynamin, a GTPase with SH3 binding domains; mediates endocytosis. | Investigating SH3 binding in membrane trafficking. |
| PEX13 | Peroxisomal membrane protein with an SH3 domain; involved in protein import. | Linking SH3 domain binding to peroxisomal disorders. |
| ABP1 | Yeast actin-binding protein with an SH3 domain; regulates cytoskeleton. | Model for binding pathway and encounter complex. |
| DRK | Drosophila adaptor protein with SH3 domains; homolog of Grb2. | Studying SH3 domain binding to Sos and Dos. |
| SOS1 | Ras guanine nucleotide exchange factor; binds Grb2 SH3 domains. | Understanding SH3-mediated Ras activation. |
| SOS2 | Ras guanine nucleotide exchange factor; interacts with SH3 domains. | Comparative studies of SH3 binding specificity. |
| DOS | Drosophila protein that binds Drk SH3 domains; regulates signaling. | Model for SH3 domain partner selection. |
| NCK1 | Adaptor protein with SH3 domains; regulates cytoskeleton and signaling. | Investigating SH3 domain interactions in cell motility. |
| NCK2 | Adaptor protein with SH3 domains; involved in neuronal development. | Studying SH3 domain binding in neurodevelopment. |
| CRK | Adaptor protein with SH3 domain; regulates cell migration. | Cancer-related SH3 domain interactions. |
| CRKL | Adaptor protein with SH3 domain; involved in leukemogenesis. | Model for SH3 domain binding in leukemia. |
| ITK | Tyrosine kinase with SH3 domain; regulates T-cell signaling. | SH3 domain binding in immune cell activation. |
| BTK | Tyrosine kinase with SH3 domain; essential for B-cell development. | SH3 domain mutations in immunodeficiency. |
| VAV1 | Guanine nucleotide exchange factor with SH3 domain; regulates actin. | SH3 domain binding in lymphocyte signaling. |
| WAS | Wiskott-Aldrich syndrome protein; binds SH3 domains; regulates actin. | SH3 domain interactions in immunodeficiency. |
How Is SH3 domain binding Regulated?
SH3 domain binding is regulated at multiple levels. The availability of binding partners can be controlled by phosphorylation, which may create or disrupt SH3 binding motifs. Intracellular localization and membrane recruitment also influence whether an SH3 domain encounters its ligand. In addition, adjacent domains within the same protein can modulate SH3 domain selectivity, as shown for Grb2 where the SH2 domain dictates binding preferences. The binding pathway itself, including the formation of a disordered encounter complex, can be affected by mutations and by the cellular environment. Finally, post-translational modifications of SH3 domains, such as nickel binding to c-Src, can affect structural stability and crystallization, hinting at potential regulatory roles.
SH3 domain binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GRB2 | Cancer (Ras pathway activation) | Knockout or point mutation of SH3 domain in cancer cell lines. |
| PEX13 | Peroxisomal biogenesis disorders (e.g., Zellweger spectrum) | Knockout or knock-in of patient mutations in cell models. |
| DNM1 | Neurological disorders (e.g., epileptic encephalopathy) | Knockout or point mutation in neuronal cells. |
| BTK | X-linked agammaglobulinemia | Knockout or point mutation in B-cell lines. |
| WAS | Wiskott-Aldrich syndrome | Knockout or knock-in of SH3 binding mutations in hematopoietic cells. |
SH3 domain binding in cancer
Dysregulated SH3 domain interactions contribute to cancer by aberrantly activating signaling pathways that control proliferation, survival, and metastasis. For example, the Grb2 SH3 domain-mediated binding to SOS is a key step in Ras activation, and mutations that alter this interaction can lead to oncogenic signaling. Targeting SH3 domain binding interfaces is therefore an active area of drug discovery.
SH3 domain binding in neurological and developmental disorders
SH3 domain binding is critical for neuronal development and function, as many adaptor proteins with SH3 domains regulate cytoskeletal dynamics and synaptic signaling. Disruption of these interactions has been linked to neurodevelopmental disorders. Additionally, peroxisomal import defects caused by mutations in PEX13, which uses an SH3 domain, lead to severe neurological and metabolic disorders.
SH3 domain binding in immune disorders
Several immune-related kinases and adaptors, such as BTK and ITK, rely on SH3 domain interactions for their function. Mutations that impair SH3 domain binding can cause immunodeficiencies, while excessive binding may contribute to autoimmune conditions. Studying these interactions helps in understanding immune cell signaling and in developing targeted therapies.
From SH3 domain binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of an SH3 domain abolish binding to a specific partner? | Knockout of the SH3 domain-encoding exon using CRISPR. |
| How does a point mutation in the SH3 domain affect binding affinity? | Point mutation knock-in via CRISPR. |
| Can a disease-associated mutation in an SH3 binding motif be corrected? | Knock-in of wild-type sequence using CRISPR. |
| Where does an SH3 domain-containing protein localize in cells? | Tagged knock-in with fluorescent protein. |
| What happens when an SH3 domain protein is overexpressed? | Overexpression via lentiviral or CRISPR activation. |
| Which genes are required for SH3 domain-mediated signaling? | CRISPR library screening. |
How to Study the SH3 domain binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Protein-binding array | Binding of SH3 domains to immobilized ligands | High-throughput interaction profiling. |
| X-ray crystallography | Three-dimensional structure of SH3 domain-ligand complex | Atomic details of binding. |
| NMR spectroscopy | Conformational dynamics and binding interfaces | Studying encounter complexes. |
| Surface plasmon resonance | Binding affinity and kinetics | Quantifying SH3 domain interactions. |
| Isothermal titration calorimetry | Thermodynamics of binding | Measuring binding enthalpy and entropy. |
| Fluorescence polarization | Binding affinity in solution | Screening for inhibitors. |
| CRISPR knockout | Loss-of-function phenotype | Testing causal role of SH3 domain proteins. |
| CRISPR knock-in | Precise mutation or tag introduction | Modeling disease mutations. |
Protein-binding arrays
SH3 domain protein-binding arrays allow high-throughput profiling of interactions between SH3 domains and their ligands. These arrays can identify new binding partners and quantify binding specificity. They are particularly useful for comparing wild-type and mutant SH3 domains.
Structural biology (X-ray crystallography, NMR)
X-ray crystallography and NMR provide atomic-level views of SH3 domain-ligand complexes. For example, nickel binding to the c-Src SH3 domain facilitates crystallization, enabling structural determination. These methods reveal the molecular details of binding and guide inhibitor design.
Biophysical assays (SPR, ITC, fluorescence)
Surface plasmon resonance (SPR), isothermal titration calorimetry (ITC), and fluorescence polarization are used to measure binding affinities and kinetics of SH3 domain interactions. These techniques can dissect the contribution of individual residues to binding energy. They are also used to study encounter complexes and folding pathways.
CRISPR-based functional genomics
CRISPR knockout, point mutation, and knock-in models enable causal testing of SH3 domain binding in cells. Library screening can identify genes that modulate SH3 domain-dependent pathways. These approaches link binding events to cellular phenotypes and disease.
How CRISPR Can Be Used to Study GO:0017124 SH3 domain binding
Knockout
CRISPR knockout of genes encoding SH3 domain-containing proteins or their binding partners can abolish specific interactions and reveal their cellular functions. For example, knocking out GRB2 can disrupt SH3 domain-mediated Ras activation. Knockout models are essential for distinguishing between redundant and essential SH3 domain interactions.
Point Mutation
Point mutations in SH3 domains or their binding motifs can be introduced using CRISPR to test the importance of individual residues for binding. For instance, mutating the conserved tryptophan in an SH3 domain can impair ligand binding. Such models help validate structural predictions and identify disease-causing mutations.
Knock-in
Knock-in of tagged or disease-associated variants allows precise tracking and functional analysis of SH3 domain proteins. For example, knocking in a fluorescent tag can reveal localization dynamics. Knock-in of patient mutations in PEX13 can model peroxisomal disorders.
Overexpression
Overexpression of SH3 domain-containing proteins or their ligands can amplify signaling and reveal gain-of-function phenotypes. This approach is useful for studying dominant-negative effects or for screening inhibitors. CRISPR activation can be used for controlled overexpression.
How EDITGENE Supports SH3 domain binding Research
Researchers studying SH3 domain binding-related genes often need to determine whether a candidate gene is causally involved in a specific signaling pathway or disease. This requires precise genetic models that can isolate the contribution of individual domains, motifs, or residues. EDITGENE provides a comprehensive suite of CRISPR services to generate such models efficiently and reproducibly.
Contact EDITGENE today to design your custom CRISPR model for SH3 domain binding research.
Frequently Asked Questions About SH3 domain binding
What is SH3 domain binding?
SH3 domain binding (GO:0017124) is the molecular function of binding to an SH3 domain, a small protein module of about 50 amino acids that mediates protein-protein interactions, often via proline-rich motifs.
What genes are involved in SH3 domain binding?
Genes encoding SH3 domain-containing proteins include SRC, GRB2, DNM1, PEX13, ABP1, DRK, NCK1, NCK2, CRK, CRKL, ITK, BTK, VAV1, and WAS, among others.
How does SH3 domain binding work?
SH3 domains recognize proline-rich sequences, and binding often proceeds through a disordered encounter complex before forming a stable complex.
What diseases are associated with SH3 domain binding?
Dysregulated SH3 domain interactions are linked to cancer, neurological disorders, peroxisomal biogenesis disorders, and immunodeficiencies.
What is the consensus motif for SH3 domain binding?
The classical consensus is a PxxP motif, but specificity is determined by additional residues outside the core motif.
How can I study SH3 domain binding in the lab?
Common methods include protein-binding arrays, X-ray crystallography, NMR, SPR, ITC, and CRISPR-based functional assays.
Can CRISPR be used to study SH3 domain binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise testing of SH3 domain function in cells.
What is the role of SH3 domain binding in cancer?
SH3 domain interactions, such as Grb2 binding to SOS, activate oncogenic signaling pathways and are targets for cancer therapy.
Which model organisms are used to study SH3 domain binding?
Yeast (e.g., Abp1p) and Drosophila (e.g., Drk) are valuable models for studying SH3 domain binding mechanisms.
How does EDITGENE support SH3 domain binding research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services to study SH3 domain binding.
Conclusion
SH3 domain binding (GO:0017124) is a fundamental molecular function that underlies diverse cellular processes, from signal transduction to cytoskeletal regulation and peroxisomal import. Its specificity is governed by the interplay between the SH3 domain and its ligand, often involving dynamic encounter complexes. Dysregulation of SH3 domain interactions contributes to cancer, neurological disorders, and immune deficiencies, making them important therapeutic targets. Advances in structural biology, biophysics, and CRISPR-based functional genomics continue to illuminate the rules of SH3 domain binding. EDITGENE's comprehensive CRISPR services empower researchers to dissect these interactions with precision and translate findings into new treatments.
References
- 1. Saksela K et al.. 2012. SH3 domain ligand binding: What's the consensus and where's the specificity?. FEBS Lett 586(17):2609-14 PMID: 22710157
- 2. Calicdan X et al.. 2025. Nickel Binding to the c-Src SH3 Domain Facilitates Crystallization.. Protein Pept Lett 32(9):679-692 PMID: 41088944
- 3. Scaife RM et al.. 1997. The role of the PH domain and SH3 binding domains in dynamin function.. Cell Signal 9(6):395-401 PMID: 9376220
- 4. Chamnongpol S et al.. 2004. SH3 domain protein-binding arrays.. Methods Mol Biol 264:183-9 PMID: 15020790
- 5. Sayeesh PM et al.. 2022. Insight into the C-terminal SH3 domain mediated binding of Drosophila Drk to Sos and Dos.. Biochem Biophys Res Commun 625:87-93 PMID: 35952612
- 6. Di Felice M et al.. 2024. The binding selectivity of the C-terminal SH3 domain of Grb2, but not its folding pathway, is dictated by its contiguous SH2 domain.. J Biol Chem 300(4):107129 PMID: 38432639
- 7. Gaussmann S et al.. 2024. Modulation of peroxisomal import by the PEX13 SH3 domain and a proximal FxxxF binding motif.. Nat Commun 15(1):3317 PMID: 38632234
- 8. Gerlach GJ et al.. 2020. A disordered encounter complex is central to the yeast Abp1p SH3 domain binding pathway.. PLoS Comput Biol 16(9):e1007815 PMID: 32925900
